Work

From DNA to Doses: How Pharmacogenomics Transforms Depression Care in Community Pharmacy

Year: 2025

Type: article

Abstract: Pharmacogenomic testing can identify these genetic variations, allowing healthcare providers to adjust drug selection and dosage accordingly. These tests typically involve a simple cheek swab or saliva sample, which is then analysed to identify specific genetic variations that affect drug metabolism and response. Cytochrome P450 (CYP450) enzyme is responsible for the metabolism of many antidepressants. CYP2D6 and CYP2C19 may cause variations in how drugs are metabolized. A neurotransmitter invol

Source: Archives of Pharmacy Practice

DOI: 10.51847/si19cmljuz

Authors: Momin Shabana, Nusrath Fatima, T. Kusuma Teja, Umar Zeshan

Institution: Osmania University

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4411660292